Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV
暂无分享,去创建一个
B. Hoen | F. Raffi | P. Pradat | P. Delobel | L. Cotte | M. Valantin | A. Frésard | I. Poizot-Martin | A. Chéret | J. Reynes | A. Cabié | D. Rey | C. Jacomet | P. Puglièse | C. Duvivier | F. Bani-Sadr | L. Hustache-Mathieu | T. Huleux
[1] Z. Younossi. The efficacy of new antiviral regimens for hepatitis C infection: Evidence from a systematic review , 2018, Hepatology.
[2] F. Zoulim,et al. Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination , 2017, BMC Medicine.
[3] M. Wainberg,et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. , 2017, The lancet. HIV.
[4] L. Cuzin,et al. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"? , 2017, The Journal of infection.
[5] A. d’Arminio Monforte,et al. Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014. , 2017, Journal of hepatology.
[6] A. Aghemo,et al. Direct-acting antivirals: the endgame for hepatitis C? , 2017, Current opinion in virology.
[7] D. Nelson,et al. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. , 2017, Annals of internal medicine.
[8] R. Simmons,et al. Evaluation of hepatitis C testing in men who have sex with men, and associated risk behaviours, in Manchester, UK , 2017, Sexually Transmitted Infections.
[9] A. Alaei,et al. Using preexposure prophylaxis, losing condoms? Preexposure prophylaxis promotion may undermine safe sex. , 2016, AIDS.
[10] A. Hoepelman,et al. Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[11] M. Egger,et al. Hepatitis C virus transmission among human immunodeficiency virus‐infected men who have sex with men: Modeling the effect of behavioral and treatment interventions , 2016, Hepatology.
[12] L. Cuzin,et al. Hepatitis C treatment initiation in HIV-HCV coinfected patients , 2016, BMC Infectious Diseases.
[13] C. Sabin,et al. Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] M. Egger,et al. Hepatitis C virus transmission among HIV-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions , 2016 .
[15] T. Anothaisintawee,et al. Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naïve Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis , 2015, PloS one.
[16] J. Willis,et al. What is chemsex and why does it matter? , 2015, BMJ : British Medical Journal.
[17] D. Stuart,et al. Increasing use of ‘party drugs’ in people living with HIV on antiretrovirals: a concern for patient safety , 2015, AIDS.
[18] J. Casabona,et al. Hepatitis C virus infection and its relationship to certain sexual practices in men-who-have-sex-with-men in Spain: results from the European MSM internet survey (EMIS). , 2015, Enfermedades infecciosas y microbiologia clinica.
[19] F. Dabis,et al. Burden of HIV and hepatitis C co‐infection: the changing epidemiology of hepatitis C in HIV‐infected patients in France , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[20] L. Cuzin,et al. A large French prospective cohort of HIV‐infected patients: the Nadis Cohort , 2009, HIV medicine.